Immix Biopharma, Inc.

Immix Biopharma, Inc. financial statements

Immix Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 29.4M10-Q
Cash and equivalentsUSD 93.93M10-Q
Total debtUSD 1.07MEODHD

Immix Biopharma, Inc. financials on 6ix · Immix Biopharma, Inc. on 6ix